By Anja Holm2024-03-06T15:00:00
Maximum residue limits (MRL) have been a requirement for all substances included in veterinary medicines intended for food-producing animals since the 1990s. The new Veterinary Medicines Regulation ([EU] 2019/6) provides an opportunity for data protection in relation to the data package submitted to the European Medicines Agency (EMA) when applicants request new or extended MRL. This could provide a real advantage for a product and may contribute to the availability of treatments for less prevalent animal species. The new rules and options deserve attention from the veterinary medicines industry. They aim to extend the range of products for use in many animal species and to repurpose old substances where generic competition is a hurdle for investment.
Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.
Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.
LoginJoin TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.
In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.
This offer ends 31 July 2024
Become a member
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud